Reilly Financial Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Reilly Financial Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,000	Closed	-$15K	–	1029
2019 Q1	$15K	Hold	1,000	–	–	﹤0.01%	598
2018 Q4	$11K	Hold	1,000	–	–	﹤0.01%	640
2018 Q3	$26K	Hold	1,000	–	–	﹤0.01%	496
2018 Q2	$20K	Hold	1,000	–	–	﹤0.01%	511
2018 Q1	$18K	Hold	1,000	–	–	﹤0.01%	529
2017 Q4	$14K	Hold	1,000	–	–	﹤0.01%	586
2017 Q3	$19K	Hold	1,000	–	–	﹤0.01%	515
2017 Q2	$17K	Hold	1,000	–	–	﹤0.01%	547
2017 Q1	$13K	Hold	1,000	–	–	﹤0.01%	567
2016 Q4	$15K	Hold	1,000	–	–	﹤0.01%	502
2016 Q3	$12K	Hold	1,000	–	–	﹤0.01%	501
2016 Q2	$11K	Hold	1,000	–	–	﹤0.01%	495
2016 Q1	$9K	Buy	+1,000	New	+$10.8K	﹤0.01%	794

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Reilly Financial Advisors's MNTA Position: Q2 2019 in Review

Reilly Financial Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2019, closing a stake of 1,000 shares — an estimated $15K sold.

Reilly Financial Advisors first reported a position in MNTA in Q1 2016 and held it in 13 quarters. The position peaked at $26K in Q3 2018. 155 funds tracked by Wall St. Rank hold MNTA as of Q2 2019.

Reilly Financial Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Reilly Financial Advisors sold 1,000 Momenta Pharmaceuticals, Inc. shares in Q2 2019, an estimated $15K.
Reilly Financial Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2016 and held it in 13 quarters.
Reilly Financial Advisors's Momenta Pharmaceuticals, Inc. position peaked at $26K in Q3 2018.
155 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2019.

Based on Reilly Financial Advisors's 13F filing for Q2 2019, filed 23 Jul 2019.